Leaper David J, van Goor Harry, Reilly Jacqueline, Petrosillo Nicola, Geiss Heinrich K, Torres Antonio J, Berger Anne
University Hospital of North Tees, Stockton on Tees, UK.
Int Wound J. 2004 Dec;1(4):247-73. doi: 10.1111/j.1742-4801.2004.00067.x.
This retrospective review of reported surgical site infection (SSI) rates in Europe was undertaken to obtain an estimated scale of the problem and the associated economic burden. Preliminary literature searches revealed incomplete datasets when applying the National Nosocomial Infection Surveillance System criteria. Following an expanded literature search, studies were selected according to the number of parameters reported, from those identified as critical for accurate determination of SSI rates. Forty-eight studies were analysed. None of the reviewed studies recorded all the data necessary to enable a comparative assessment of the SSI rate to be undertaken. The estimated range from selected studies analysed varied widely from 1.5-20% - a consequence of inconsistencies in data collection methods, surveillance criteria and wide variations in the surgical procedures investigated - often unspecified. SSIs contribute greatly to the economic costs of surgical procedures - estimated range: 1.47-19.1 billion Euro dollars. The analysis suggests that the true rate of SSIs, currently unknown, is likely to have been previously under-reported. Consequently, the associated economic burden is also likely to be underestimated. A significant improvement in study design, data collection, analysis and reporting will be necessary to ensure that SSI baseline rates are more accurately assessed to enable the evaluation of future cost-effective measures.
开展此次对欧洲报告的手术部位感染(SSI)率的回顾性研究,以获取该问题的估计规模及相关经济负担。初步文献检索显示,应用国家医院感染监测系统标准时数据集不完整。在扩大文献检索范围后,根据报告参数的数量从那些被确定为准确确定SSI率的关键参数中选择研究。对48项研究进行了分析。没有一项被审查的研究记录了进行SSI率比较评估所需的所有数据。所选研究分析得出的估计范围差异很大,为1.5%-20%,这是数据收集方法、监测标准不一致以及所调查手术程序差异很大(通常未明确说明)的结果。手术部位感染对手术程序的经济成本贡献巨大,估计范围为14.7亿至191亿欧元。分析表明,目前未知的手术部位感染真实发生率可能此前报告不足。因此,相关经济负担也可能被低估。要确保更准确地评估手术部位感染基线率,以便能够评估未来的成本效益措施,就必须在研究设计、数据收集、分析和报告方面有显著改进。